S L Haskell
- Epidemiology
- Pharmacology top 5%
- Molecular Medicine top 5%
- Molecular Biology
- Infectious Diseases top 10%
- Co-authors
- Thomas D. GootzD GirardA. R. EnglishJames A. RetsemaAgnès GirardJ. A. FaiellaRichard P. ZaniewskiR J Polzer
- Topics
- Antibiotics Pharmacokinetics and Efficacy (6 papers)Cancer therapeutics and mechanisms (4 papers)Antibiotic Resistance in Bacteria (3 papers)
- Journals
- Journal of Clinical MicrobiologyAntimicrobial Agents and ChemotherapyThe Journal of Antibiotics
- Partner nations
- United StatesChina
In The Last Decade
S L Haskell
8 papers receiving 532 citations
Peers
Comparison fields: 5 of 83
- Epidemiology 228
- Pharmacology 221
- Molecular Medicine 168
- Molecular Biology 143
- Infectious Diseases 128
Countries citing papers authored by S L Haskell
This map shows the geographic impact of S L Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S L Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S L Haskell more than expected).
Fields of papers citing papers by S L Haskell
This network shows the impact of papers produced by S L Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S L Haskell. The network helps show where S L Haskell may publish in the future.
Co-authorship network of co-authors of S L Haskell
This figure shows the co-authorship network connecting the top 25 collaborators of S L Haskell. A scholar is included among the top collaborators of S L Haskell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S L Haskell. S L Haskell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 114 | |
| 3 | 37 | |
| 4 | 30 | |
| 5 | 39 | |
| 6 | 269 | |
| 7 | 29 | |
| 8 | 21 |
About S L Haskell
S L Haskell is a scholar working on Molecular Medicine, Pharmacology and Small Animals, having authored 8 papers that have together received 569 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Molecular Medicine (168 citations), Pharmacology (221 citations) and Applied Microbiology and Biotechnology (15 citations). S L Haskell has collaborated with scholars based in United States and China. Frequent co-authors include Thomas D. Gootz, D Girard, A. R. English, James A. Retsema, Agnès Girard, J. A. Faiella, Richard P. Zaniewski, R J Polzer, Patrice Courvalin and Jacques Tankovic. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.